The Food and Drug Administration (FDA) is inviting public feedback on its proposed collection of information related to adverse events and product experiences for FDA-regulated products. As part of fulfilling requirements under the Paperwork Reduction Act, the FDA seeks comments on whether this information collection is necessary, its accuracy, and ways to minimize the burden on respondents. They have updated forms and processes to standardize data collection, improve quality and clarity, and ensure confidentiality where necessary. The deadline for providing comments, either electronically or by mail, is March 18, 2025.
Simple Explanation
The FDA wants to hear people's thoughts about how they collect information when something goes wrong with their products or when people use them. They have made some changes to make it easier and safer to share this information, and people can tell the FDA what they think until March 18, 2025.